Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022
July 26, 2022 at 06:10 pm EDT
Entheon Biomedical Corp. reported earnings results for the second quarter and six months ended May 31, 2022. For the second quarter, the company reported sales was CAD 0.011984 million compared to CAD 0.001457 million a year ago. Net loss was CAD 1.27 million compared to CAD 2.41 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.04 a year ago.
For the six months, sales was CAD 0.020885 million compared to CAD 0.001457 million a year ago. Net loss was CAD 3.14 million compared to CAD 5.3 million a year ago. Basic loss per share from continuing operations was CAD 0.05 compared to CAD 0.1 a year ago.